RT @ISNeducation: @DrAbhiNephro A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis https://t.co/XXGrHXSjl0 Main focus…
@DrAbhiNephro A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis https://t.co/XXGrHXSjl0 Main focus is on cardiac amyloidosis
#JACCHF How has mortality for systemic AL #amyloidosis changed since 2009? Researchers from the #Stanford University address the overall trends in mortality since the adoption of modern therapies for AL amyloidosis. #cardiotwitter #Cardiology @JACCJournals
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
RT @JACCJournals: How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed…
How has mortality for systemic AL #amyloidosis changed over the last decade? A team of researchers from @StanfordDeptMed led by Dr. @Ron_Witteles investigate mortality risk in relationship to disease stage in this month's #JACCHF. https://t.co/m01q5oCEpT h
#Clinicalquestion When screening for AL-Amyloid, we look at Kappa:Lamda ratio; our @JACCJournals reviews and Guidelines, state to refer to Heme/Onc when ratio > 3:1.. most heme/onc docs, aren't "concerned" until ratio > 10:1... what is your practic
RT @rhythmkris: Survival in AL amyloid is improving, but 80% of mortality is cardiac and 30% SCD. So, who might benefit from #ICD? https://…
Survival in AL amyloid is improving, but 80% of mortality is cardiac and 30% SCD. So, who might benefit from #ICD? https://t.co/rkZna4AOOd
A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis. https://t.co/ELhQfvigfv
A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis. https://t.co/31yzLXbxUx
RT @coconnormd: A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis | JACC: Heart Failure: Improving survival amongst a…
A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis | JACC: Heart Failure: Improving survival amongst a treatable form of HFpEF https://t.co/nTi1OfDTOv